CSIMarket
 


Inhibitor Therapeutics Inc   (HPPI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

HPPI's Capital Expenditures Growth by Quarter and Year

Inhibitor Therapeutics Inc 's Capital Expenditures results by quarter and year




HPPI Capital Expenditures (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 0.00 - - -
FY   - - - -



HPPI Capital Expenditures first quarter 2020 Y/Y Growth Comment
Inhibitor Therapeutics Inc in the first quarter recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the first quarter, Inhibitor Therapeutics Inc achieved the best Capital Expenditures growth in Biotechnology & Drugs industry. While Inhibitor Therapeutics Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the first quarter.




HPPI Capital Expenditures ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Inhibitor Therapeutics Inc 's first quarter 2020 Capital Expenditures $ 0.00 millions HPPI's Income Statement
Inhibitor Therapeutics Inc 's first quarter 2019 Capital Expenditures $ 0.00 millions Quarterly HPPI's Income Statement
New: More HPPI's historic Capital Expenditures Growth >>


HPPI Capital Expenditures (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Capital Expenditures first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Inhibitor Therapeutics Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HPPI's I. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HPPI's I. Quarter Q/Q Capital Expenditures Comment


Inhibitor Therapeutics Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Mar 31 2020 period, Inhibitor Therapeutics Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Inhibitor Therapeutics Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Mar 31 2020 period, Inhibitor Therapeutics Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Inhibitor Therapeutics Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Biotechnology & Drugs Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
HPPI's Capital Expenditures Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for HPPI's Competitors
Capital Expenditures Growth for Inhibitor Therapeutics Inc 's Suppliers
Capital Expenditures Growth for HPPI's Customers

You may also want to know
HPPI's Annual Growth Rates HPPI's Profitability Ratios HPPI's Asset Turnover Ratio HPPI's Dividend Growth
HPPI's Roe HPPI's Valuation Ratios HPPI's Financial Strength Ratios HPPI's Dividend Payout Ratio
HPPI's Roa HPPI's Inventory Turnover Ratio HPPI's Growth Rates HPPI's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2020
Orasure Technologies Inc -1.26 %$ -1.256 millions
Beigene Ltd -1.35 %$ -1.351 millions
Spero Therapeutics Inc -2.47 %$ -2.469 millions
Neuronetics Inc -2.92 %$ -2.920 millions
Myriad Genetics Inc -3.23 %$ -3.226 millions
Celcuity Inc -4.28 %$ -4.276 millions
Kaleido Biosciences Inc -4.53 %$ -4.529 millions
Standard Diversified Inc -4.67 %$ -4.674 millions
Johnson and Johnson -4.73 %$ -4.726 millions
Fibrogen Inc -4.97 %$ -4.969 millions
Vanda Pharmaceuticals Inc -5.09 %$ -5.089 millions
Tenet Healthcare Corp -5.15 %$ -5.155 millions
Hanger Inc -5.38 %$ -5.379 millions
Biolife Solutions Inc -6.41 %$ -6.410 millions
Endologix Inc -6.54 %$ -6.542 millions
Kyto Technology and Life Science Inc -7.82 %$ -7.819 millions
Intuitive Surgical Inc -8.36 %$ -8.362 millions
Bristol Myers Squibb Co -8.82 %$ -8.824 millions
Dynatronics Corp -8.92 %$ -8.923 millions
Integrated Biopharma Inc -9.52 %$ -9.524 millions
Viveve Medical Inc -10.06 %$ -10.056 millions
Heska Corp -10.26 %$ -10.256 millions
Icu Medical Inc -10.45 %$ -10.447 millions
Milestone Scientific Inc -11.92 %$ -11.920 millions
Veracyte Inc -13.07 %$ -13.072 millions
Baxter International Inc -13.13 %$ -13.131 millions
Eventbrite Inc -13.22 %$ -13.215 millions
Blueprint Medicines Corporation -13.84 %$ -13.842 millions
Dexcom Inc -15.52 %$ -15.522 millions
Bionik Laboratories Corp -15.58 %$ -15.577 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNWV's Profile

Stock Price

SNWV's Financials

Business Description

Fundamentals

Charts & Quotes

SNWV's News

Suppliers

SNWV's Competitors

Customers & Markets

Economic Indicators

SNWV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071